Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-03

Clinical Trial Update: Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer [Phase 4]

View source ↗

Summary

Phase 4 trial comparing amorolfine 5% nail lacquer to ciclopirox nail lacquer for treatment of onychomycosis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclopirox Nail Lacquer (ciclopirox)
  • Loceryl (Amorolfine)

Snippet

Sponsor: Galderma R&D | Conditions: Foot Dermatoses | Phase 4 | Status: COMPLETED | Results posted: 2018-10-03